< Terug naar vorige pagina
Octrooi
Biomarkers for disease burden of neuroblastoma
The present invention relates to monitoring disease and therapy response. More in particular, the present invention discloses serum/plasma miRNA markers for assessment of disease burden in human neuroblastoma. Indeed, the present invention discloses that the more the tumor is spread throughout the body, the higher the levels of particular miRNAs in serum/plasma are. Consequently, the latter markers can be used in methods and kits for assessing the neuroblastoma disease burden.
Octrooi-publicatienummer: WO2019115214
Jaar aanvraag: 2019
Jaar toekenning: 2020
Jaar van publicatie: 2019
Status: Aangevraagd
URI: link to Espacenet
Technologiedomeinen: Biotechnologie
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie Universiteit Gent